Company Presentation

AlphaMol combines artificial intelligence and in-house cutting-edged biotechnology, aiming at advancing pre-clinical GPCR drug discovery in an ultimately efficient way. AlphaMol has invented several first-in-class PCC within 3-9 months, which usually takes 5-7 years to achieve via traditional way. In the GPCR-DOCK 2021 global contest, AlphaMol defeated AlphaFold2, with 60% higher accuracy. Both co-founders are in the list of “top 2%” scientists in the world.